What is Zacks Small Cap’s Estimate for MGRM Q1 Earnings?

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) – Equities research analysts at Zacks Small Cap issued their Q1 2025 earnings per share estimates for shares of Monogram Orthopaedics in a report issued on Thursday, March 13th. Zacks Small Cap analyst T. Kerr expects that the company will earn ($0.10) per share for the quarter. The consensus estimate for Monogram Orthopaedics’ current full-year earnings is ($0.49) per share. Zacks Small Cap also issued estimates for Monogram Orthopaedics’ Q2 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.13) EPS, FY2025 earnings at ($0.44) EPS and FY2026 earnings at ($0.16) EPS.

Several other equities research analysts also recently issued reports on MGRM. Roth Capital upgraded Monogram Orthopaedics to a “strong-buy” rating in a research report on Monday, December 9th. Roth Mkm assumed coverage on Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 price objective on the stock.

Monogram Orthopaedics Trading Up 57.5 %

MGRM opened at $3.67 on Monday. Monogram Orthopaedics has a 12 month low of $1.53 and a 12 month high of $4.90. The company has a market cap of $129.51 million, a PE ratio of -7.81 and a beta of 1.66. The company has a 50 day moving average of $2.56 and a 200 day moving average of $2.49.

Monogram Orthopaedics (NASDAQ:MGRM) last posted its earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.03.

Hedge Funds Weigh In On Monogram Orthopaedics

Several hedge funds have recently bought and sold shares of MGRM. Jane Street Group LLC bought a new position in Monogram Orthopaedics in the 4th quarter valued at $25,000. Northern Trust Corp raised its position in shares of Monogram Orthopaedics by 110.6% in the fourth quarter. Northern Trust Corp now owns 45,873 shares of the company’s stock worth $109,000 after buying an additional 24,088 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company’s stock worth $27,000 after buying an additional 8,597 shares in the last quarter. Geode Capital Management LLC grew its position in Monogram Orthopaedics by 7.7% during the fourth quarter. Geode Capital Management LLC now owns 226,378 shares of the company’s stock worth $537,000 after buying an additional 16,234 shares in the last quarter. Finally, Orion Portfolio Solutions LLC purchased a new position in Monogram Orthopaedics during the fourth quarter worth about $31,000. Hedge funds and other institutional investors own 0.45% of the company’s stock.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.